{"id":"NCT00141817","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating Pantoprazole in Children With GERD","officialTitle":"A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years With Endoscopically Proven GERD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2005-09-01","resultsPosted":"2011-12-28","lastUpdate":"2011-12-28"},"enrollment":41,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastroesophageal Reflux"],"interventions":[{"type":"DRUG","name":"pantoprazole for approximately 9 weeks.","otherNames":[]}],"arms":[],"summary":"The purpose of this study is to characterize the PK profile, safety and tolerability of single and multiple doses of pantoprazole in children aged 1 through 11 years with endoscopically proven GERD.","primaryOutcome":{"measure":"Maximum Observed Plasma Concentration (Cmax)","timeFrame":"Predose (0 hour), and 0.5, 1, 2, 4, 6, 12 hours postdose","effectByArm":[{"arm":"Pantoprazole 0.6 mg/kg Spheroids","deltaMin":136,"sd":127},{"arm":"Pantoprazole 1.2 mg/kg Spheroids","deltaMin":798,"sd":729},{"arm":"Pantoprazole 0.6 mg/kg Tablets","deltaMin":1643,"sd":1229},{"arm":"Pantoprazole 1.2 mg/kg Tablets","deltaMin":2067,"sd":1320}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":23,"countries":["United States"]},"refs":{"pmids":["21740077"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":["Abdominal pain","Diarrhea","Accidental injury","Vomiting","Upper respiratory infection"]}}